Ken Griffin Biolife Solutions Inc Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Biolife Solutions Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 11,600 shares of BLFS stock, worth $291,276. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,600
Previous 7,500
54.67%
Holding current value
$291,276
Previous $139,000
78.42%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding BLFS
# of Institutions
169Shares Held
46.4MCall Options Held
11.6KPut Options Held
800-
Casdin Capital, LLC New York, NY8.71MShares$219 Million16.16% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$138 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.32MShares$83.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.79MShares$70 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$39.7 Million0.17% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.07B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...